EasyCheck360®
Non-Invasive Test to Detect Most Cancers Early in Asymptomatic Individuals
Non-Invasive Test to Detect Most Cancers Early in Asymptomatic Individuals
Click to view EasyCheck360® FAQs.
EasyCheck360® is a reliable and safe blood test designed to identify the presence of solid organ cancer at an early stage, making it easier for doctors to make important, potentially life-saving decisions about your care.
This advanced and non-invasive test requires just a quick and simple blood draw. It works by identifying Circulating Tumour Cells (CTCs) that may have entered the bloodstream from a tumour. The test carefully examines these cells using a specialised process called immunocytochemistry (ICC). It is a powerful and versatile tool for early cancer detection, capable of identifying up to 30 different types of cancer.
EasyCheck360® offers peace of mind with a straightforward, quick, and accurate method for cancer screening.
EasyCheck360® detects Circulating Tumour Cells (CTCs), which are found in most types of solid organ cancers. Research shows that CTCs can be identified even in the very early stages of cancer, such as Stage 0 (tissue confined to its original place), as well as Stage I and Stage II cancers. These cells are present in all types of solid organ tumours, in both men and women, but they are not found in individuals without cancer or in those with non-cancerous (benign) tumours. This makes CTC detection a highly accurate method for identifying cancer at an early stage.
EasyCheck360® uses advanced, proven technology to provide a safe and convenient way to screen multiple types of solid organ cancers at an early stage. EasyCheck360® has demonstrated exceptional accuracy, making it a trusted choice for proactive cancer screening.